FAGLIGE KONKLUSIONER OG BEGRUNDELSE FOR ÆNDRING AF MARKEDSFØRINGSTILLADELSERNE FOR HBVAXPRO FREMLAGT AF EMEA
SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION OF THE MARKETING AUTHORISATION OF HBVAXPRO PRESENTED BY THE EMEA